Showing 34,798 results

Filters
New & experimental hepatitis C treatment

Achillion Provides Update on Clinical HCV Development Programs

Editor's pick
Achillion press release
13 November 2012
New & experimental hepatitis C treatment

Hep C Competitors Cede Space To Gilead And Bristol-Myers And Turn To Niche Uses

Editor's pick
Seeking Alpha
13 November 2012
New & experimental hepatitis C treatment

Gilead Climbs on Study Results of Hepatitis C Combination

Editor's pick
Bloomberg
12 November 2012
New & experimental hepatitis C treatment

Novartis' Certican succeeds in liver transplant trial

Editor's pick
Reuters
12 November 2012
New & experimental hepatitis C treatment

AASLD-GI-5005 Improves Virologic Clearance of HCV in Combination with PegIFN/Ribavirin in IL28B T/T Patients

Editor's pick
HCV New Drugs Research
12 November 2012
New & experimental hepatitis C treatment

Abbott interferon-free combination 'promising' in harder-to-treat patients with hepatitis C

News
12 November 2012
Men who have sex with men (MSM)

Report: Uganda’s Speaker Promises To Pass Anti-Homosexuality Bill in Two Weeks

Editor's pick
Box Turtle Bulletin
12 November 2012
New & experimental hepatitis C treatment

High rate of response to BMS HCV drugs in harder-to-treat patients – but interferon-free prospects differ by sub-genotype

News
12 November 2012
New & experimental hepatitis C treatment

Final study results show telaprevir is safe and effective for HIV/HCV co-infected people

News
12 November 2012

"Mild growth" in private US, EU funding for HIV

Editor's pick
IRIN
12 November 2012
Finance & funding

"Mild growth" in private US, EU funding for HIV

Editor's pick
IRIN Plus News
12 November 2012
New & experimental hepatitis C treatment

Gilead, Abbott Unwrap Dueling Hep C Pill Data

Editor's pick
The Street
12 November 2012
Sex workers

Malawi sex workers unite in push for better health care

Editor's pick
Africa Review
12 November 2012
Access to healthcare

Study shows drug patents can be extended for decades

Editor's pick
Intellectual Property Watch
12 November 2012
Treatment interruptions

Pegylated interferon may maintain HIV suppression and reduce viral DNA integration

Editor's pick
HIVandHepatitis.com
12 November 2012
New & experimental hepatitis C treatment

New hepatitis C drugs danoprevir and mericitabine are safe and effective for prior non-responders and people with cirrhosis

News
12 November 2012
New & experimental HIV treatments

FDA approves new 800mg PREZISTA® (darunavir) tablet

Editor's pick
Janssen press release
12 November 2012
Hepatitis C symptoms & diagnosis

New cohort shows the impact of hepatitis B and hepatitis C on the 'baby boom' generation

News
11 November 2012
New & experimental hepatitis C treatment

ALS-2200 (VX-135), Vertex's Oral Nucleotide Analogue in Development for Hepatitis C

Editor's pick
Vertex press release
11 November 2012
Cancer

The connection between Fatty Liver Disease and the Increase in the Rate of Liver Cancer

Editor's pick
AASLD press release
11 November 2012
New & experimental hepatitis C treatment

Twice-Daily Telaprevir Achieved Viral Cure (SVR12) Rates Similar to Those Treated Three Times Daily

Editor's pick
Vertex press release
11 November 2012
New & experimental hepatitis C treatment

Boehringer Ingelheim to start late-stage hepatitis C drug trial

Editor's pick
Reuters
11 November 2012
New & experimental hepatitis C treatment

Idenix Reports On IDX719 and IDX184

Editor's pick
Idenix press release
11 November 2012
Hepatitis C transmission & prevention

Hepatitis C-Safeguarding the Medical Injection Process

Editor's pick
HCV New Drugs Research
10 November 2012